Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

CD4 count news

Show

From To
Second Edition of UNITAID Diagnostic Technology Landscape Report Published

The second edition of the UNITAID Diagnostic Technology Landscape is now available online. First published in June 2011, the report has proven a critical tool for those interested in understanding the pipeline for HIV point-of-care diagnostics, including global health institutions, health care providers, investors, and developers. The 2012 edition represents UNITAID’s continued effort to map the landscape of existing and pipeline products and provides updated information on progress in the development of these important technologies.

Published
26 June 2012
From
UNITAID
Low-cost Australian HIV test to reach poor

A crucial new low-cost blood test for HIV sufferers in developing countries that could help 33 million people worldwide may be available later this year. The CD4 test, which gives on-the-spot results in 40 minutes, measures an individual's CD4 levels, which indicate whether HIV is progressing to AIDS.

Published
20 June 2012
From
NineMSN
Rapid CD4 cell testing as part of HIV testing and counselling increases chances that people will be successfully linked to care

The use of rapid, point-of-care CD4 cell tests increases the chances that people diagnosed with HIV when using mobile HIV counselling and testing  (HCT) services will be

Published
06 June 2012
By
Michael Carter
Rapid CD4 cell count performs well in HIV care and is highly acceptable to UK patients

A finger-prick test that provides CD4 cell count results within an average of 30 minutes is as accurate as laboratory-based testing and highly acceptable to patients, UK

Published
28 May 2012
By
Michael Carter
Predictive tool could cut HIV test costs

A tool to monitor how HIV-positive patients respond to antiretroviral therapy (ART) could free up scarce personnel and laboratory resources in developing countries, according to an international team of researchers.

Published
08 May 2012
From
SciDev Net
Discordance between CD4 cell count and percentage associated with markers of liver disease in HIV/hepatitis C co-infected people

Discordance between CD4 cell count and CD4 cell percentage in people co-infected with HIV and hepatitis C is associated with markers of liver fibrosis and other indicators of

Published
09 April 2012
By
Michael Carter
Liver fibrosis increases risk of discordance in CD4 cell count and percentage in HIV-positive people

Liver fibrosis is associated with discordance between CD4 cell counts and percentages in HIV-positive people, according to US research published in the online edition of Clinical Infectious Diseases.

Published
09 April 2012
By
Michael Carter
Point-of-care CD4 test improves retention and treatment initiation in Mozambique

The use of a point-of-care CD4 cell count test dramatically reduced the rate of loss to follow-up among patients diagnosed with HIV at clinics in Mozambique and

Published
28 September 2011
By
Keith Alcorn
Rapid CD4 Testing Sharply Cuts HIV Patient Dropout Rate

With the use of new rapid test kits -- which measure immune system health without having to send samples off site to laboratories and waiting for results -- researchers in Mozambique nearly doubled treatment enrollment and cut the number of patients lost almost in half.

Published
28 September 2011
From
PBS Newshour
Variations in mitochondrial DNA affect CD4 gains in black patients taking successful HIV therapy

Variations in mitochondrial DNA are associated with poorer CD4 cell gains after the initiation of antiretroviral therapy in non-Hispanic black patients, US investigators report in the online

Published
09 August 2011
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.